A new multicountry study has delivered an uncomfortable reality check. India has the highest prevalence of multidrug-resistant organisms (MDRO) carriage among patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), with 83% testing positive before the procedure. The findings come from a global effort spanning India, Italy, the United States, and the Netherlands, and they arrive at a time when antimicrobial resistance is rapidly outpacing our ability to contain it. A global comparison that puts India in the spotlight While 83% of Indian patients carried resistant organisms, the numbers were significantly lower elsewhere.
Italy recorded about 31%, the United States had around 20%, and the Netherlands reported roughly 10%. The species distribution followed the same gradient. India had the highest burden of extended-spectrum beta-lactamase (ESBL)-producing organisms at…
